Doliver Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,083
| Closed | -$201K | – | 152 |
|
|
2022
Q3 | $201K | Sell |
3,083
-1,334
| -30% | -$87K | 0.07% | 137 |
|
|
2022
Q2 | $268K | Sell |
4,417
-639
| -13% | -$38.8K | 0.1% | 131 |
|
|
2022
Q1 | $317K | Sell |
5,056
-1
| -0% | -$63 | 0.1% | 128 |
|
|
2021
Q4 | $313K | Buy |
5,057
+1,301
| +35% | +$80.5K | 0.1% | 121 |
|
|
2021
Q3 | $420K | Buy |
3,756
+962
| +34% | +$108K | 0.14% | 115 |
|
|
2021
Q2 | $452K | Sell |
2,794
-756
| -21% | -$122K | 0.15% | 93 |
|
|
2021
Q1 | $433K | Buy |
+3,550
| New | +$433K | 0.16% | 91 |
|